The antigenic link between thyroid autoimmunity and breast cancer

Area of Science:

• Endocrinology
• Oncology
• Immunology

Background:

• The association between benign thyroid disorders, particularly thyroid autoimmunity, and breast cancer has been a long-standing topic of debate.
• Autoantibodies to thyroid peroxidase (TPO), a marker of thyroid autoimmunity, are more prevalent in breast cancer patients.
• Previous studies suggested a correlation between TPO autoantibody positivity and improved breast cancer prognosis, though this finding lacks consistent confirmation.

Purpose of the Study:

• To explore the biological basis for the association between thyroid autoimmunity and breast cancer.
• To identify potential shared antigens between the thyroid and mammary glands that could explain the observed link.
• To investigate the role of thyroid peroxidase (TPO) and lactoperoxidase in the immune response relevant to both conditions.

Main Methods:

• Review of existing literature on thyroid autoimmunity, breast cancer, and shared antigens.
• Analysis of the expression patterns of key proteins like sodium iodide symporter, thyroid peroxidase, and lactoperoxidase in both thyroid and breast tissues.
• Examination of immunological cross-reactivity between autoantibodies and these shared antigens.

Main Results:

• Thyroid peroxidase (TPO) is expressed in both thyroid and breast tissues, making it a primary candidate for shared antigenicity.
• Lactoperoxidase, structurally similar to TPO, is found in neoplastic breast cells and can elicit cross-reactivity with TPO autoantibodies.
• The sodium iodide symporter, while present in both glands, is less likely to be the key antigen due to the rarity of associated autoantibodies.

Conclusions:

• Thyroid peroxidase represents the main antigenic link between thyroid autoimmunity and breast cancer due to its expression in both tissues.
• Lactoperoxidase contributes to this association through cross-reactivity with TPO autoantibodies in breast cancer cells.
• Understanding this antigenic relationship may lead to novel diagnostic and therapeutic strategies for breast cancer.